The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Platinum-based chemotherapy in patients with castration-resistant prostate cancer and hepatic metastases.
 
Gunhild Von Amsberg
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck; MSD; Pfizer; Roche Pharma AG
Speakers' Bureau - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Serono; MSD Oncology; Pfizer; Roche
Research Funding - AvenCell (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Lilly (Inst); MSD Oncology (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Janssen Oncology; Pfizer/EMD Serono; Roche
 
Lukas Lunger
No Relationships to Disclose
 
Christopher Darr
Honoraria - Janssen
Consulting or Advisory Role - Janssen
Travel, Accommodations, Expenses - Ipsen; Janssen
 
Nadja Strewinsky
No Relationships to Disclose
 
Tobias Busenbender
No Relationships to Disclose
 
Moritz Kaune
No Relationships to Disclose
 
Pierre Tennstedt
No Relationships to Disclose
 
Lisa Steinhelfer
No Relationships to Disclose
 
Margitta Retz
No Relationships to Disclose
 
Markus Sauer
No Relationships to Disclose
 
Amir Karimzadeh
No Relationships to Disclose
 
Timo Bartel
No Relationships to Disclose
 
Ken Herrmann
Leadership - Pharma15; SOFIE; Theragnostics
Stock and Other Ownership Interests - Aktis Oncology; Pharma15; SOFIE; Theragnostics
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; Bain Capital; Bayer; BTG; GE Healthcare; IPSEN; ITG (Inst); Novartis; ROTOP Pharmaka (Inst); Siemens Healthineers
 
Boris A. Hadaschik
Consulting or Advisory Role - ABX Advanced biochemical compounds; Amgen; Amgen; Astellas Pharma; Bayer; BMS GmbH & Co. KG; Janssen; Lightpoint medical; Merck KGaA; MSD; Novartis; Onkowissen; POINT Biopharma
Research Funding - Bristol Myers Squibb (Inst); Janssen; Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Uromed
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BMS; Janssen
 
Viktor Grünwald
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb; Genmab; MSD; Seagen
Honoraria - Advanced Accelerator Applications/Novartis; Apogepha; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; Merck Serono; MSD Oncology; Nanobiotix; Ono Pharmaceutical; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Cor2Ed; Cureteq; Debiopharm Group; Eisai; Gilead Sciences; Ipsen; Janssen-Cilag; MSD Oncology; Novartis; Oncorena; Onkowissen; PCI Biotech; Pfizer
Research Funding - Amgen (Inst); BMS (Inst); Gilead Sciences (Inst); Ipsen (Inst); MSD Oncology (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Merck Serono; Pfizer
 
Wolfgang P. Fendler
Honoraria - Parexel
Consulting or Advisory Role - Calyx; Janssen
Speakers' Bureau - Bayer; Janssen; Novartis; Telix Pharmaceuticals
Research Funding - SOFIE